Navigation Links
Semafore's PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
Date:10/26/2007

SAN FRANCISCO, Oct. 26 /PRNewswire/ -- Semafore Pharmaceuticals Inc. announced today on the occasion of a poster presentation at the 2007 AACR-NCI- EORTC International Conference in San Francisco that its integrin-targeted PI3 kinase inhibitor, SF1126, showed synergistic effects with certain standard chemotherapy agents in vitro and in vivo (poster C207).

In vitro data showed significant (p<0.001) synergistic growth inhibition of prostate cancer cells with combinations of docetaxel and SF1126, as well as synergistic growth inhibition of brain cancer cells with combinations of doxorubicin and SF1126. In addition, SF1126 and rapamycin showed excellent growth inhibition synergies across all prostate, renal and non-small cell lung cancer cell lines. Simultaneous dosing of SF1126 with docetaxel in a prostate xenograft model exhibited slightly improved tumor response time versus administering SF1126 prior to docetaxel administration. In this same xenograft model, using very large tumors, it was shown that SF1126 in combination with docetaxel gave significantly greater tumor regression than did docetaxel alone (p<0.05). SF1126 as a single agent showed significant tumor growth inhibition relative to the control group (73% inhibition, p<0.01) in this model as well.

"These data support that our lead compound, SF1126, is active as a single agent and in synergy with a growing list of standard chemotherapy agents," said Edward Jacobs, Semafore's president and chief executive officer. "This provides us with a pathway to clinical development in addition to our current phase I clinical trial in patients with solid tumors. We expect to complete our phase I clinical trial in the second quarter of 2008 and then evaluate SF1126 in additional trials, both as a single and combined therapy."

About SF1126

SF1126 is a small molecule conjugate containing a pan-PI3K inhibitor that selectively inhibits all PI3K class IA isoforms and other key members of the PI3K
'/>"/>

SOURCE Semafore Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
2. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Critical Double-Stranded DNA Repair Protein, Rad51
3. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
4. AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and Drug-Resistant Lung Cancer
5. Pharmacyclics Announces Presentations on Its Novel and Selective HDAC and Brutons Tyrosine Kinase Inhibitor Compounds
6. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
9. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
10. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
11. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015  Cardica, Inc. (Nasdaq: CRDC ... quarter ended March 31, 2015. Cardica,s management will hold ... discuss the financial results and provide an update on ... the third quarter of fiscal 2015, we reintroduced a ... white cartridges only. This controlled commercial release is focusing ...
(Date:5/6/2015)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company ... products and services, today reported total revenues of $37.8 million ... compared to revenues of $37.1 million for the first quarter ... or $0.12 per share, basic and $0.11 per share, diluted, ... of $15.7 million, or $0.13 per share, basic and diluted, ...
(Date:5/6/2015)... BioPharma Corp. (NASDAQ and MTA: CTIC) today reported financial ... "After reporting positive top-line results ... during the quarter, we have subsequently received positive feedback ... by the potential opportunity for pacritinib to meet a ... with myelofibrosis, specifically in the portion of patients that ...
Breaking Medicine Technology:Cardica Announces Fiscal 2015 Third Quarter Financial Results 2Cardica Announces Fiscal 2015 Third Quarter Financial Results 3Cardica Announces Fiscal 2015 Third Quarter Financial Results 4Cardica Announces Fiscal 2015 Third Quarter Financial Results 5Cardica Announces Fiscal 2015 Third Quarter Financial Results 6Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 2Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 3Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 4Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 5Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 6Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 7Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 8Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 9Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 10Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 11Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 12CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9
... , SUNNYVALE, Calif., Dec. 16 ... field of radiosurgery, announced today that its president and chief executive ... 28th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ... A live webcast of each presentation will be available online from ...
... CHICAGO, Dec. 16 A new application developed ... of specialty pharmaceuticals has increased health plan staff productivity and ... a leading diagnostic imaging benefit management and technology company with ... operating subsidiary of WellPoint, Inc. (NYSE: WLP ), ...
Cached Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4
(Date:5/6/2015)... MJNational LLC strengthens its consultant agreement ... Bizcard ™ platform. This exciting new SMS platform creates ... Sales / Services. Now you can reach out ... products, services and ticker symbol through an easy to ... LLC will provide managed support and services to advance ...
(Date:5/6/2015)... Edvance360 LMS-SN , a leader ... the Software & Information Industry Association's (SIIA) 30th ... Postsecondary Learning Management Solution" category. Edvance360 LMS-SN won ... for this award seven years running, continued proof that ... the industry. , "The honor of being a ...
(Date:5/6/2015)... Mass. (PRWEB) May 06, 2015 ... today announced that CTO David Ting will lead a ... the associated data security and user authentication challenges, during ... Fla.). The session will focus on the benefits of ... in which care providers and patients can share information. ...
(Date:5/6/2015)... As Hilo Medical Center progressed ... Model, the hospital looked for new applications that ... processes. The leadership team realized that while many ... patient registration still required patients to apply ink-on-paper ... Stage 7 attestation fast approaching, Hilo looked for ...
(Date:5/6/2015)... On April 27, 2015, Elle Magazine ... ,” compiled quotes about cosmetic surgery from 16 celebrities. ... Iggy Azalea, and Gwyneth Paltrow. For the most part, ... plastic surgery themselves; only a couple of the ... of youth and beauty. (see: goo.gl/wSomih) , “The quotes ...
Breaking Medicine News(10 mins):Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2
... ... in biofeedback and Mediwatch plc team up to offer a range of pelvic floor ... ... manufacturing company, and Thought Technology Ltd., the worldwide leading expert in biofeedback, have entered ...
... SATURDAY, July 3 (HealthDay News) -- One way to ... fireworks celebrations to the experts, a children,s eye specialist ... Adults, and particularly children, should not play with these ... Dr. Daniel Neely, a pediatric ophthalmologist at the Indiana ...
... David Ettenberg, owner of ... and reality don,t always mesh in how "fat camps" (and the overweight teenage campers who attend ... ... bit of fantasy, our lives would be mighty dull and TV producers know that better than ...
... ... ... From self-published author Don Pilcher comes a gripping novel where two adult siblings discover ... lives of twins Frank and Trina, and the danger that follows them. , , ...
... ... complete resource for anyone in need of a mobility solution for their home. Customers will ... ... US Medical Supplies, an online retailer of more than 10,000 medical and mobility products, announced ...
... ... Inc.,s Magnolia Shop Sells Natural and Organic Meat Raised Locally, , ... Seattle, WA (PRWEB) July 2, 2010 ... the company’s total to five, said J’Amy Owens, chief executive officer., , ,Located at ...
Cached Medicine News:Health News:OEM Partnership Between Thought Technology Ltd. and Mediwatch plc 2Health News:OEM Partnership Between Thought Technology Ltd. and Mediwatch plc 3Health News:Leave July 4 Fireworks to the Pros 2Health News:Real Life "Fat Camp" Owner Disagrees With How Such Camps Are Depicted In ABC Family's new show, "Huge" 2Health News:Real Life "Fat Camp" Owner Disagrees With How Such Camps Are Depicted In ABC Family's new show, "Huge" 3Health News:New Book Tells of a Dark Secret that Puts Adult Twins on the Opposite Sides of the Law 2Health News:US Medical Supplies Publishes 2010 Catalog 2Health News:In Time for July 4th Grilling, Bill the Butcher Opens 5th Butcher Shop 2
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
... For more than 20 years, AMS ... various healthcare and industrial clients in ... Accuracy, Convenience, Speed, and Economy. Always ... remain focused on the individual needs ...
... the Division of Pathology and Laboratory Medicine ... nation's largest and most comprehensive academic medical ... 700 employees and more than 40 pathologists ... million laboratory test results, interpretations and diagnostic ...
ChildLab is a service of Children's Hospital, Columbus Ohio...
Medicine Products: